Refractory lupus hepatitis successfully treated with telitacicept who failed to belimumab: A case report and literature review

Conclusion: This case suggests that telitacicept should be an effective and safe treatment for LH refractory, even to those who failed to belimumab based on the standard treatment, and can reduce the dosage of glucocorticoids.However, further investigations, particularly prospective randomized controlled trials, are warranted to verify our findings and ensure patient safety.PMID:38320748 | DOI:10.1177/09612033241233021
Source: Lupus - Category: Rheumatology Authors: Source Type: research